Clinical Trials Directory

Trials / Sponsors / Kang Stem Biotech Co., Ltd.

Kang Stem Biotech Co., Ltd.

Industry · 17 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingLong-Term Follow-up Study of Subjects With Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in K0
Knee Osteoarthritis
—2023-09-14
UnknownEvaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis
Knee Osteoarthritis
Phase 1 / Phase 22023-07-06
Not Yet RecruitingLong-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj
Atopic Dermatitis
—2022-03-27
UnknownSafety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)
Dermatitis, Atopic
Phase 32021-06-29
UnknownSafety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic De
Atopic Dermatitis
Phase 1 / Phase 22021-01-27
UnknownLong-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)
Rheumatoid Arthritis
—2019-10-02
UnknownAdministration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients
Atopic Dermatitis
—2019-08-29
UnknownEvalution the Safety and Efficacy in Atopic Dermatitis Patients
Atopic Dermatitis
—2019-04-05
CompletedSafety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 1 / Phase 22018-07-11
CompletedSafety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)
Atopic Dermatitis
Phase 32018-04-25
UnknownSafety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis
Psoriasis
Phase 12018-01-17
UnknownLong-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.
Atopic Dermatitis
—2016-07-01
UnknownLong-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj
Rheumatoid Arthritis
—2016-06-29
UnknownLong-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)
Crohn's Disease
—2015-11-01
CompletedSafety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA)
Rheumatoid Arthritis
Phase 12014-10-01
UnknownSafety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)
Crohn's Disease
Phase 1 / Phase 22014-08-01
CompletedSafety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD
Atopic Dermatitis
Phase 1 / Phase 22013-09-01